Hemodynamic and inotropic effects of nitric oxide in pulmonary hypertension

Journal of Surgical Research

Volumn 69, Issue 2, 1997, Pages 288-294

  Chen, Edward P ^a,b   Bittner, Hartmuth B ^a   Davis, R Duane ^a   Van Trigt, Peter ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MONOCROTALINE PYRROLE; NITRIC OXIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; CARDIOPULMONARY HEMODYNAMICS; CONFERENCE PAPER; CONTROLLED STUDY; DOG; HEART RIGHT VENTRICLE FAILURE; HEART RIGHT VENTRICLE FUNCTION; INHALATIONAL DRUG ADMINISTRATION; INOTROPISM; LUNG BLOOD FLOW; NONHUMAN; PRIORITY JOURNAL; PULMONARY HYPERTENSION; VASODILATATION;

EID: 0031148480     PISSN: 00224804     EISSN: None     Source Type: Journal    
DOI: 10.1006/jsre.1997.5031     Document Type: Conference Paper

References (26)

1. 1. Wahlers, T., Beer, C., Fieguth, H. G., Cremer, J., Jurmann, M., Schäfers, H. J., et al. Right heart failure following orthotopic cardiac transplantation. Clin. Transplant. 2: 252, 1988.
2. 1, and sodium nitroprusside. J. Heart Lung Transplant. 14: 436, 1995.
3. 3. Williams, T. J., Salamonsen, R. F., Snell, G., Kaye, D., and Esmore, D. S. Preliminary experience with inhaled nitric oxide for acute pulmonary hypertension after heart transplantation. J. Heart Lung Transplant. 14: 419, 1995.
4. 4. Chen, E. P., Bittner, H. B., Tull, F., Biswas, S., Davis, R. D., and Van Trigt, P. An adult canine model of chronic pulmonary hypertension for cardiopulmonary transplantation. J. Heart Lung Transplant. 15: S55, 1996.
5. 5. Mattocks, A. R., Jukes, R., and Brown, J. Simple procedures for preparing putative toxic metabolites of pyrrolizidine alkaloids. Toxicon 27: 561, 1989.
6. 6. Glower, D. D., Spratt, J. A., Snow, N. D., et al. Linearity of the Frank-Starling relationship in the intact heart: the concept of preload recruitable stroke work. Circulation 71: 994, 1985.
7. 7. Milnor, W. R. Hemodynamics. Baltimore: Williams and Wilkins, 1989.
8. 8. Long, W. A., and Rubin, L. J. Prostacyclin and PGE1 treatment of pulmonary hypertension. Am. Rev. Respir. Dis. 136: 773, 1987.
9. 9. Ignarro, L. J., Buga, G. M., Wood, K. S., Byrns, R. E., and Chaudhuri, G. Endothelium-derived relaxing factor produced and released form artery and vein is nitric oxide. Proc. Natl. Acad. Sci. U.S.A. 84: 9265, 1987.
10. 10. Palmer, R. M. J., Ferrige, A. G., and Moncada, S. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 327: 524, 1987.
11. 11. Ignarro, L. Biological actions and properties of endothelial-derived nitric oxide formed and released from artery and vein. Circ. Res. 65: 1, 1989.
12. 12. Lunn, R. J. Inhaled nitric oxide therapy. Mayo Clin. Proc. 70: 247, 1995.
13. 13. Weitzberg, E., Rudehill, A., and Lundberg, J. M. Nitric oxide inhalation attenuates pulmonary hypertension and improves gas exchange in endotoxin shock. Eur. J. Pharmacol. 233: 85, 1993.
14. 14. Hillman, N. D., Meliones, J. N., Black, D. R., Craig, D. M., Cheifetz, I. M., and Smith, P. K. In acute lung injury, inhaled nitric oxide improves ventilation-perfusion matching, pulmonary vascular mechanics, and transpulmonary vascular efficiency. J. Thorac. Cardiovasc. Surg. 110: 593, 1995.
15. 15. Adatia, I., Perry, S., Landzberg, M., Moore, P., Thompson, J. E., and Wessel, D. L. Inhaled nitric oxide and hemodynamic evaluation of patients with pulmonary hypertension before transplantation. J. Am. Coll. Cardiol. 25: 1656, 1995.
16. 16. Semigran, M. J., Cockrill, B. A., Kacmarek, R., Thompson, B. T., Zapol, W. M., Dec, G. W., and Fifer, M. A. Hemodynamic effects of inhaled nitric oxide in heart failure. J. Am. Coll. Cardiol. 24: 982, 1994.
17. 17. Bocchi, E. A., Bacal, F., Auler, J. O. C., Carmone, M. J. C., Bellotti, G., and Pileggi, F. Inhaled nitric oxide leading to pulmonary edema in stable severe heart failure. Am. J. Cardiol. 74: 70, 1994.
18. 18. Snell, G. I., Salamonsen, R. F., Bergin, P., Esmore, D. S., Khan, S., and Williams, T. J. Inhaled nitric oxide used as a bridge to heart-lung transplantation in a patient with end-stage pulmonary hypertension. Am. J. Respir. Crit. Care. Med. 151: 1263, 1995.
19. 19. Silove, E. D., Tavernor, W. D., and Berry, C. L. Reactive pulmonary arterial hypertension after pulmonary venous constriction in the calf. Cardiovasc. Res. 6: 36, 1972.
20. 20. McLean, R. F., Prielipp, R. C., Rosenthal, M. H., and Pearl, D. G. Vasodilator therapy in microembolic porcine pulmonary hypertension. Anesth. Analg. (N.Y.) 71: 35, 1990.
21. 21. Hsieh, C. M., Mishkel, G. J., Cardoso, P. F. G., et al. Production and reversibility of right ventricular hypertrophy and right heart failure in dogs. Ann. Thorac. Surg. 54: 104, 1992.
22. 22. Roth, R. A., and Reindel, J. F. Lung vascular injury from monocrotaline pyrrole, a putative hepatic metabolite. Adv. Exp. Med. Biol. 283: 477, 1991.
23. 23. Bittner, H. B., Kendall, S. W. H., Chen, E. P., Craig, D., and Van Trigt, P. The effects of brain death on cardiopulmonary hemodynamics and pulmonary blood flow characteristics. Chest 108: 1358, 1995.
24. 24. Attinger, E. O., Anne, A., and McDonald, D. A. Use of Fourier series for the analysis of biological systems. Biophys. J. 6: 291, 1966.
25. 25. Wormersley, J. R. Oscillatory flow in arteries. Phys. Med. Biol. 2: 178, 1957.
26. 26. Shah, A. M., Prendergast, B. D., Grocott-Mason, R., Lewis, M. J., and Paulus, W. J. The influence of endothelium-nitric oxide on myocardial contractile function. Int. J. Cardiol. 50: 225, 1995.